Hydroxyl-glutarimidedioxime: a complexing reagent to strip uranium from the organic phase of P350
Year: 2025
Type: article
Language: en
Topic: Radioactive element chemistry and processing
Authors and affiliations:
raw_author_name: Yuyu Liang
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Bijun Liu
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Xiang Li
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Zhuoxi Li
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Shufeng Zhao
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Qingye Zhou
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Chenchen Yuan
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Zeng Huang
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China
raw_author_name: Xingliang Li
raw_affiliation_strings: CAEA, Center of Excellence on Nuclear Technology Application for Radioisotope and Radiopharmaceutical, Nuclear Medicine and Theragnostic Key Laboratory of Sichuan Province, Targeted Radiopharmaceuticals Creation Key Laboratory of Sichuan Province, Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621999, China